Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 333-342, February 2007

AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes

  • Girish Kewalramani

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
    • These two authors contributed equally to the work reported here.
  • ,
  • Ding An

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
    • These two authors contributed equally to the work reported here.
  • ,
  • Min Suk Kim

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Sanjoy Ghosh

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Dake Qi

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Ashraf Abrahani

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Thomas Pulinilkunnil

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Vijay Sharma

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Richard B. Wambolt

      Affiliations

    • Department of Pathology and Laboratory Medicine, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Michael F. Allard

      Affiliations

    • Department of Pathology and Laboratory Medicine, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Sheila M. Innis

      Affiliations

    • Department of Pediatrics, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
  • ,
  • Brian Rodrigues

      Affiliations

    • Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z3
    • Corresponding Author InformationCorresponding author. Tel.: +1 604 822 4758; fax: +1 604 822 3035.

Received 13 September 2006; received in revised form 18 October 2006; accepted 13 November 2006.

Abstract 

Flexibility in substrate selection is essential for the heart to maintain production of energy and contractile function, and is managed through multiple mechanisms including PPAR-α and AMP-activated protein kinase (AMPK). Rats injected with 55 mg/kg STZ (D55) were kept for 4 days (acute diabetes; D55-A) prior to termination. Fatty acid (FA) oxidation increased in D55-A hearts, with no significant change in gene expression of PPAR-α, or its downstream targets. However, both AMPK and ACC phosphorylation were significantly higher in these hearts, effects that were reversed by insulin. Unexpectedly, when the duration of diabetes in D55 rats was extended to 6 weeks (chronic diabetes; D55-C), AMPK and ACC phosphorylation were comparable in control and D55-C hearts. In D55-C rat hearts, lack of AMPK activation was closely associated to an overload of plasma and cardiac lipids. To validate the relationship between lipids and cardiac AMPK activation, we either induced more severe diabetes (100 mg/kg STZ to provoke both hyperglycemia and hyperlipidemia acutely; D100-A) or infused intralipid (IL) to enlarge circulating lipids. There was no difference in cardiac AMPK and ACC phosphorylation in D100-A rats compared to control. Measurement of AMPK and ACC phosphorylation in control and D55-A hearts revealed that their phosphorylation was inhibited by acute intralipid infusion. Our data suggest that activation of AMPK is an adaptation that would ensure adequate cardiac energy production when glucose utilization is compromised. However, in severe diabetes, with the addition of augmented plasma and heart lipids, AMPK activation is prevented, and control of FA oxidation is likely through alternate mechanisms. Given that AMPK plays an important role in preventing cardiac ischemic/reperfusion damage, it is possible that in these diabetic hearts, the accelerated damage observed during exposure to ischemia/reperfusion could be a likely outcome of a compromised activation of AMPK.

Keywords: Diabetes, Heart, Fatty acids, Metabolism, Insulin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-2828(06)01029-7

doi:10.1016/j.yjmcc.2006.11.010

Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 333-342, February 2007